Effect of nutritional status on survival outcome of diffuse large B-cell lymphoma patients treated with rituximab-CHOP

Nutrition and Cancer

Volumn 66, Issue 2, 2014, Pages 225-233

  Park, Silvia ^a   Han, Boram ^b   Cho, Jae Won ^c   Woo, Sook Young ^c   Kim, Seonwoo ^c   Kim, Seok Jin ^a   Kim, Won Seog ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Hallym University Sacred Heart Hospital   (South Korea)

^c Samsung Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREALBUMIN; PREDNISONE; RITUXIMAB; SERUM ALBUMIN; TRANSFERRIN; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARM MUSCLE; ARTICLE; BODY MASS; CANCER SURVIVAL; FEBRILE NEUTROPENIA; FEMALE; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MIDDLE AGED; NUTRITIONAL PARAMETERS; NUTRITIONAL STATUS; PROSPECTIVE STUDY; SKINFOLD; TREATMENT OUTCOME; TUMOR VOLUME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTHROPOMETRY; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BODY MASS INDEX; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; FEBRILE NEUTROPENIA; FEMALE; HUMANS; L-LACTATE DEHYDROGENASE; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MALNUTRITION; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITION ASSESSMENT; NUTRITIONAL STATUS; PREDNISONE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VINCRISTINE; YOUNG ADULT;

EID: 84895099613     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2014.867065     Document Type: Article

References (24)

1. Tisdale MJ: Cachexia in cancer patients. Nat Rev Cancer 2, 862-871, 2002. (Pubitemid 37328904)
2. Gordon JN, Green SR, and Goggin PM: Cancer cachexia. QJM98, 779-788, 2005. (Pubitemid 41631328)
3. McMillan DC: Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 12, 223-226, 2009.
4. Alexandre J, Gross-Goupil M, Falissard B, Nguyen ML, Gornet JM, et al.: Evaluation of the nutritional and inflammatory status in cancer patients for the risk assessment of severe haematological toxicity following chemotherapy. Ann Oncol 14, 36-41, 2003. (Pubitemid 36150256)
5. Arrieta O, Michel Ortega RM, Villanueva-Rodriguez G, Serna-Thome MG., Flores-Estrada D, et al.: Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study. BMC Cancer 10, 50, 2010.
6. Barret M, Malka D, Aparicio T, Dalban C, Locher C, et al.:Nutritional status affects treatment tolerability and survival in metastatic colorectal cancer patients: results of an AGEO prospective multicenter study. Oncology 81, 395-402, 2011.
7. The International Non-Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's lymphoma. NEngl J Med 329, 987-994, 1993.
8. The Non-Hodgkin's Lymphoma Classification Project: A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 89, 3909-3918, 1997.
9. Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, et al.: CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346, 235-242, 2002. (Pubitemid 34438862)
10. Pfreundschuh M, Trumper L, Osterborg A, Pettengell R, Trneny M, et al.: CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the Mab Thera International Trial (MInT) Group. Lancet Oncol 7, 379-391, 2006.
11. Feugier P, Van Hoof A, Sebban C, Solal-Celigny P, Bouabdallah R, et al.: Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 23, 4117-4126, 2005. (Pubitemid 46211317)
12. Ziepert M, Hasenclever D, Kuhnt E, Glass B, Schmitz N, et al.: Standard International Prognostic Index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era. J Clin Oncol 28, 2373-2380, 2010.
13. Jang G, Yoon DH, Kim S, Lee DH, Lee SW, et al.: Addition of rituximab to the CHOP regimen has no benefit in patients with primary extranodal diffuse large B-cell lymphoma. Korean J Hematol 46, 103-110, 2011.
14. Pettengell R, Johnson HE, Lugtenburg PJ, Silvestre AS, Duhrsen U, et al.: Impact of febrile neutropenia on R-CHOP chemotherapy delivery and hospitalizations among patients with diffuse large B-cell lymphoma. Support Care Cancer 20, 647-652, 2012.
15. Dobrila-Dintinjana R, Trivanovic D, Zelic M, Radic M, Dintinjana M, et al.: Nutritional support in patients with colorectal cancer during chemotherapy: does it Work? Hepatogastroenterology 60, 475-480, 2012.
16. Robinson DL, Loman DG, Balakas K, and Flowers M: Nutritional screening and early intervention in children, adolescents, and young adults with cancer. J Pediatr Oncol Nurs 29, 346-355, 2012.
17. Sarhill N, Mahmoud F, Walsh D, Nelson KA, Komurcu S, et al.: Evaluation of nutritional status in advanced metastatic cancer. Support Care Cancer 11, 652-659, 2003. (Pubitemid 37243596)
18. McMillan DC: An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc 67, 257-262, 2008.
19. Tah PC, Nik Shanita S, and Poh BK: Nutritional status among pediatric cancer patients: a comparison between hematological malignancies and solid tumors. J Spec Pediatr Nurs 17, 301-311, 2012.
20. D'Angio RG: Is there a role for albumin administration in nutrition support? Ann Pharmacother 28, 478-482, 1994. (Pubitemid 24123765)
21. Fleck A., Raines G., Hawker F., Trotter J., Wallace P. I., et al.: Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury. Lancet 1, 781-784, 1985. (Pubitemid 15111938)
22. Devoto G, Gallo F, Marchello C, Racchi O, Garbarini R, et al.: Prealbumin serum concentrations as a useful tool in the assessment of malnutrition in hospitalized patients. Clin Chem 52, 2281-2285, 2006. (Pubitemid 44925003)
23. Aoki T, Nishiyama T, Imahashi N, and Kitamura K: Lymphopenia following the completion of first-line therapy predicts early relapse in patients with diffuse large B cell lymphoma. Ann Hematol 91, 375-382, 2012.
24. Kim YR, Kim JS, Kim SJ, Jung HA, Kim WS, et al.: Lymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthracycline-containing chemotherapy. J Hematol Oncol 4, 34 2011.